https://invesbrain.com/the-access-to-advanced-health-institute-receives-18-million-award-to-develop-a-temperature-stable-single-dose-chikungunya-rna-vaccine-through-a-phase-1-clinical-trial/
The Access to Advanced Health Institute receives $18 million award to develop a temperature stable, single-dose chikungunya RNA vaccine through a phase 1 clinical trial